Ocuphire Pharma (OCUP)
NASDAQ:OCUP

Ocuphire Pharma (OCUP) Financial Statements

957 Followers

Ocuphire Pharma Financial Overview

Ocuphire Pharma's market cap is currently ―. The company's EPS TTM is $-0.486; its P/E ratio is -4.19; Ocuphire Pharma is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 1.71M$ 1.69M$ 11.94M$ 3.67M$ 1.75M
Gross Profit$ 1.71M$ 1.69M$ 11.94M$ 3.67M$ 1.75M
EBIT$ -7.11M$ -4.80M$ 5.58M$ -4.96M$ -5.79M
EBITDA$ -7.11M$ -4.79M$ 5.58M-$ -5.79M
Net Income Common Stockholders$ -7.11M$ -4.79M$ 6.89M$ -4.96M$ -5.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 47.20M$ 50.52M$ 42.41M$ 40.02M$ 39.02M
Total Assets$ 51.84M$ 53.95M$ 54.19M$ 43.49M$ 45.45M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -47.20M$ -50.52M$ -42.41M$ -40.02M$ -39.02M
Total Liabilities$ 5.79M$ 4.04M$ 3.91M$ 5.76M$ 4.15M
Stockholders Equity$ 46.06M$ 49.91M$ 50.28M$ 37.70M$ 41.25M
Cash Flow-
Free Cash Flow$ -5.72M$ 4.55M$ -3.00M-$ -3.65M
Operating Cash Flow$ -5.72M$ 4.55M$ -3.00M-$ -3.65M
Investing Cash Flow-----
Financing Cash Flow$ 2.38M$ 3.60M$ 5.38M--
Currency in USD

Ocuphire Pharma Earnings and Revenue History

Ocuphire Pharma Debt to Assets

Ocuphire Pharma Cash Flow

Ocuphire Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis